Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Acura Pharma Cmn (ACUR)

Acura Pharma Cmn (ACUR)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 7,034
  • Shares Outstanding, K 21,650
  • Annual Sales, $ 2,660 K
  • Annual Income, $ -4,989 K
  • 60-Month Beta 1.20
  • Price/Sales 2.85
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.05
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 12/31/19
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.2800 +16.04%
on 07/02/20
0.3650 -10.99%
on 07/07/20
-0.0121 (-3.59%)
since 06/10/20
3-Month
0.1360 +138.90%
on 04/16/20
0.4000 -18.78%
on 05/22/20
+0.0249 (+8.30%)
since 04/09/20
52-Week
0.1200 +170.75%
on 03/09/20
0.6300 -48.43%
on 11/08/19
+0.1238 (+61.56%)
since 07/10/19

Most Recent Stories

More News
Acura Pharmaceuticals Announces First Quarter 2020 Financial Results

Acura Pharmaceuticals, Inc. (OTCQB: ACUR), a specialty pharmaceutical company engaged in the research, development and commercialization of technologies and product candidates intended to mitigate the...

ACUR : 0.3249 (-7.14%)
Respiratory Diseases Drugs Market Analysis - Global Outlook and Anlaysis of COVID-19 Implications for the Industry

, /PRNewswire/ -- The report has been added to offering.

ACUR : 0.3249 (-7.14%)
The global opioids drugs market is anticipated to grow at a CAGR of 2.48% over the forecast period of 2019-2028

, /PRNewswire/ -- The global opioids drugs market is anticipated to grow at a CAGR of 2.48% over the forecast period of 2019-2028. The major factors augmenting the global market growth are the growing...

ACUR : 0.3249 (-7.14%)
AGN : 193.02 (+0.02%)
BDSI : 4.22 (+1.44%)
COLL : 16.73 (-2.39%)
EGLT : 0.0315 (-63.37%)
HKMPF : 27.5000 (-0.18%)
LCI : 5.74 (-7.12%)
PFE : 33.83 (+1.11%)
TEVA : 11.76 (+1.29%)
Acura Pharmaceuticals Announces Fourth Quarter and Full Year 2019 Financial Results

Acura Pharmaceuticals, Inc., a specialty pharmaceutical company engaged in the research, development and commercialization of technologies and product candidates intended to mitigate the risk of outcomes...

ACUR : 0.3249 (-7.14%)
Acura Pharmaceuticals Provides an Update on the Development of LTX-03

Acura Pharmaceuticals, Inc. (OTCQB: ACUR), today announced that Abuse Deterrent Pharma, LLC, its licensee of LTX-03 (Hydrocodone Bitartrate and Acetaminophen with Acura's LIMITx(TM) Technology), has engaged...

ACUR : 0.3249 (-7.14%)
Acura Pharmaceuticals Announces Third Quarter 2019 Financial Results

Acura Pharmaceuticals, Inc. (OTC: ACUR), a specialty pharmaceutical company engaged in the research, development and commercialization of technologies and product candidates intended to mitigate the risk...

ACUR : 0.3249 (-7.14%)
Acura Pharmaceuticals Announces Second Quarter 2019 Financial Results

Acura Pharmaceuticals, Inc., a specialty pharmaceutical company engaged in the research, development and commercialization of technologies and product candidates intended to mitigate the risk of outcomes...

ACUR : 0.3249 (-7.14%)
Acura Pharmaceuticals Provides an Update on the Development of LTX-03

Acura Pharmaceuticals, Inc. (OTC Pink: ACUR), today provided an update on its development of LTX-03 (Hydrocodone Bitartrate and Acetaminophen) Tablets using Acura's LIMITx(TM) technology intended to mitigate...

ACUR : 0.3249 (-7.14%)
Acura Pharmaceuticals Announces First Quarter 2019 Financial Results

Acura Pharmaceuticals, Inc., a specialty pharmaceutical company engaged in the research, development and commercialization of technologies and product candidates intended to mitigate the risk of outcomes...

ACUR : 0.3249 (-7.14%)
Acura Pharmaceuticals Announces Fourth Quarter 2018 and Full Year 2018 Financial Results

Acura Pharmaceuticals, Inc., a specialty pharmaceutical company engaged in the research, development and commercialization of technologies and product candidates intended to mitigate the risk of outcomes...

ACUR : 0.3249 (-7.14%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Buy with a Weakest short term outlook on maintaining the current direction.

See More Share

Trade ACUR with:

Key Turning Points

2nd Resistance Point 0.3814
1st Resistance Point 0.3531
Last Price 0.3249
1st Support Level 0.2933
2nd Support Level 0.2618

See More

52-Week High 0.6300
Fibonacci 61.8% 0.4352
Fibonacci 50% 0.3750
Last Price 0.3249
Fibonacci 38.2% 0.3148
52-Week Low 0.1200

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar